ABBVIE INC (NYSE: ABBV)

Overview
current price
$209.03
$209.03
change
4.01 | 1.96%
4.01 | 1.96%
Yesterday's Close
205.02
open
205.12
volume
13.14 M
30d. avg volume.
6.10 M
1 day
204.41 - 209.60
52 weeks
153.58 - 207.32
p/e
87.46
beta
0.5780
market cap
369.01 B
dividend yield
3.14%
Industry
-
News and Commentary
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Exper... Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.This growth w...
AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains AbbVie Inc (ABBV ...
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine Johnson & Johnson (JNJ&...
Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It '... Merck & Co Inc (MRK&nbs...
Drug Maker Games the Patent System to Rake in $114 Billion The pharmaceutical giant AbbVie (
October 28 Market Summary Global investors on Friday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index edged up 0.14%, the British FTSE dipped 0.37%, the German...
October 25 Market Summary Global investors on Tuesday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index soared 3.23%, the British FTSE edged down 0.01%, the Germ...
Pfizer to Acquire Migraine Drugmaker Biohaven for $11.6 Billion Pfizer (PFE 
StockTwits
StockTwits